Will Geron be acquired? The long-short view

Jakob Uszko­r­e­it, one of the peo­ple who laid the ground­work for gen­er­a­tive plat­forms such as Chat­G­PT, has se­cured $100 mil­lion in a Se­ries A raise

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

The Eu­ro­pean Med­i­cines Agency is con­cerned there could be a po­ten­tial link be­tween thy­roid can­cer and the use of glucagon-like pep­tide-1 (GLP-1) re­cep­tor ag­o­nists, which